IP Verse

Use Of A Reverse-Transcriptase Inhibitor In The Prevention And Treatment Of Degenerative Diseases

Patent No. EP3212200 (titled "Use Of A Reverse-Transcriptase Inhibitor In The Prevention And Treatment Of Degenerative Diseases") was filed by Centre National DE LA Recherche Scientifique on Oct 30, 2015. The application was issued on Jan 20, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
SCHLICHJun 18, 2021SCHLICH

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3212200

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
Application Number
EP15798211A
Filing Date
Oct 30, 2015
Status
Granted And Under Opposition
Dec 18, 2020
Publication Date
Jan 20, 2021
External Links
Slate, Register , Google Patents